Cargando…
Prediction of the treatment response in ovarian cancer: a ctDNA approach
ABSTRACT: Ovarian cancer is the eighth most commonly occurring cancer in women. Clinically, the limitation of conventional screening and monitoring approaches inhibits high throughput analysis of the tumor molecular markers toward prediction of treatment response. Recently, analysis of liquid biopsi...
Autores principales: | Sharbatoghli, Mina, Vafaei, Somayeh, Aboulkheyr Es, Hamidreza, Asadi-Lari, Mohsen, Totonchi, Mehdi, Madjd, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574472/ https://www.ncbi.nlm.nih.gov/pubmed/33076944 http://dx.doi.org/10.1186/s13048-020-00729-1 |
Ejemplares similares
-
Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients
por: Sharbatoghli, Mina, et al.
Publicado: (2022) -
The Association Between Higher Expression of Talin-1 and the Reduced Survival Rate in Ovarian Serous Carcinoma Patients
por: Sharbatoghli, Mina, et al.
Publicado: (2023) -
Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma
por: Sharbatoghli, Mina, et al.
Publicado: (2022) -
Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP)
por: Es, Hamidreza Aboulkheyr, et al.
Publicado: (2021) -
HNF4α is possibly the missing link between epithelial–mesenchymal transition and Warburg effect during hepatocarcinogenesis
por: Shokouhian, Bahare, et al.
Publicado: (2022)